| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 405,819 | 8,056 | 378,473 | 308,619 | | Cost of Revenue | 145,534 | 3,247 | 313,355 | 5,082 | | | Gross Profit | 260,285 | 4,809 | 65,118 | 303,537 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 215,406 | 9,187 | 10,143 | 268,545 | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 14,563 | 5,836 | 10,162 | 9,576 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 30,316 | (10,214) | 44,813 | 25,416 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (110) | 1,712 | (662) | 1,018 | | Earnings Before Interest And Taxes | 30,206 | (8,502) | 44,151 | 25,975 | | Interest Expense | 7,695 | 5,822 | 6,287 | 6,806 | | Income Before Tax | 22,511 | (14,324) | 37,864 | 19,169 | | Income Tax Expense | 7,423 | (4,804) | 14,533 | 7,727 | | Minority Interest |
-
|
-
|
-
| (217) | | | | Net Income From Continuing Ops | 15,090 | (9,520) | 23,331 | 11,225 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income |
-
| (9,520) | 23,331 | 11,225 | | Preferred Stock And Other Adjustments |
-
| (275) | (210) | (8,522) | | | Net Income Applicable To Common Shares | $14,276 | ($9,795) | $23,121 | $2,703 |
|
0.51% Nasdaq 
Income Statement
